Detalles de la búsqueda
1.
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs.
Liver Int;
40(3): 539-548, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31241820
2.
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R).
Z Gastroenterol;
58(4): 341-351, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32040979
3.
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
Gut;
68(6): 1099-1107, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30068662
4.
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma.
Br J Cancer;
120(1): 109-114, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30377340
5.
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies.
BMC Cancer;
19(1): 72, 2019 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30646854
6.
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
J Hepatol;
68(4): 663-671, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133244
7.
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers.
J Hum Genet;
63(5): 621-626, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29483677
8.
Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas.
Histopathology;
72(6): 997-1006, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29243296
9.
Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization.
Int J Mol Sci;
19(10)2018 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30347788
10.
Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
J Lipid Res;
58(1): 247-255, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836992
11.
The overall fatty acid absorption controlled by basolateral chylomicron excretion under regulation of p-JNK1.
Biochim Biophys Acta Mol Cell Biol Lipids;
1862(9): 917-928, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602806
12.
Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer.
Br J Cancer;
113(9): 1343-9, 2015 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26461054
13.
Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Eur J Clin Invest;
45(9): 925-31, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26108973
14.
Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis.
FASEB J;
28(7): 3159-70, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24719358
15.
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort.
BMC Gastroenterol;
15: 97, 2015 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26239732
16.
Ursodeoxycholyl lysophosphatidylethanolamide inhibits lipoapoptosis by shifting fatty acid pools toward monosaturated and polyunsaturated fatty acids in mouse hepatocytes.
Mol Pharmacol;
84(5): 696-709, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23974795
17.
Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Hepatology;
55(5): 1369-78, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22183915
18.
The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
Hepatology;
66(2): 666-667, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28176361
19.
The influence of haemodialysis on haemodynamic measurements using transpulmonary thermodilution in patients with septic shock: an observational study.
Eur J Anaesthesiol;
30(1): 16-20, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22935958
20.
Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome.
J Clin Med;
12(22)2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38002661